Evolving experience of treating antibody-mediated rejection following lung transplantation

The importance of antibody-mediated rejection (AMR) following lung transplantation remains contentious. In particular, the diagnostic criteria suggested to define AMR, namely the presence of donor-specific antibodies (DSA), C4d immunoreactivity, histological features and allograft dysfunction are not always readily applicable or confirmatory in lung transplantation. In a retrospective single-center study of 255 lung transplant recipients (LTR),...